Forward Progress: ESG Primer on Clinical Trial Diversity

In this multi-analyst, multi-industry report, Cowen Research provides the first of its kind analysis of the current state of clinical trial diversity. There’s accelerating ESG investor interest in clinical trial diversity as a metric of a medical product company’s commitment to access within the Social element of ESG.  We seek to provide:

  • a robust assessment of the current state of clinical trial representation
  • the nuances of different technologies and diseases
  • an understanding of the steps companies are taking
  • insight into where areas of progress are sorely lacking

This report focuses on diseases that disproportionately affect certain racial, ethnic, sexual identity, or gender subgroups, as well as an assessment of the steps companies are taking to improve trial diversity. We also spoke with several KOLs, including regulatory and CRO experts as well as KOLs that work with minority groups to improve access to and representation in clinical studies.

By clicking above, I agree that Cowen may use and store the personal information I provide to interact with me. See also https://cowen.com/privacy

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

More Like This

Boy playing with green paper plane in green field. The boy is flying the plane through the air. Sustainable air travel concept for a piece on sustainable aviation fuel and the aviation industries ESG & Net Zero commitments.
Ahead of the Curve®

Sustainable Growth in Sustainable Fuels

Read More
Podcast
Celebrating pride month our Luxury analyst Oliver Chen, spoke with the CEO of Neman Marcus. This image of a rainbow flag pin on a designer blazer is meant to both represent Neman Marcus as a brand and pride month as well as celebrating and fighting for Lgbtq+ rights and inclusion in the workplace.

Digitization In Luxury with Neiman Marcus Group CEO

Read More
Image of rising buildings and nature invocating ESG investing
Ahead of the Curve®

7th Annual Sustainability & Energy Transition Primer

Read More